Ibutilide Fumarate (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Ibutilide Fumarate drug offered from Mylan Institutional LLC. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Ibutilide Fumarate
SUBSTANCE NAME: IBUTILIDE FUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-01-11
END MARKETING DATE: 0000-00-00


Ibutilide Fumarate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIbutilide Fumarate from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.1(mg/mL)
START MARKETING DATE: 2010-01-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-366_7e63ba88-36c9-4228-917c-f9a92c86965e
PRODUCT NDC: 67457-366
APPLICATION NUMBER: ANDA090643

Other IBUTILIDE FUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GeneraMedix Inc.Ibutilide Fumarate
Mylan Institutional LLCIbutilide Fumarate
Pharmacia and Upjohn CompanyCorvert
Pharmacia and Upjohn Company LLCCorvert